Volume 31, Number 1—January 2025
Dispatch
Fatal Case of Crimean-Congo Hemorrhagic Fever, Portugal, 2024
Table 2
Category (reference limit range) |
D2 |
D6 |
D7 |
D8 |
D9 |
D10 |
D11 |
Hemoglobin, g/dL (14.0–17.5) |
12.9 |
11.6 |
10.5 |
11.6 |
10.6 |
9.4 |
8.8 |
Leukocytes, 109 cells/L (4.4–11.3) |
7.83 |
5.95 |
4.50 |
4.83 |
3.64 |
2.94 |
2.36 |
Neutrophils, 109 cells/L |
7.44 |
4.22 |
3.11 |
3.10 |
2.82 |
2.29 |
1.82 |
Lymphocytes, 109 cells/L |
0.24 |
1.49 |
1.22 |
1.56 |
0.71 |
0.57 |
0.50 |
Platelet count, 109/L (150–450) |
156 |
6 |
5 |
7 |
13 |
14 |
10 |
C-reactive protein, mg/dL |
0.15 |
3.44 |
1.95 |
1.57 |
0.75 |
0.66 |
1.03 |
Prothrombin time, s (9.4–12.5) |
11.5 |
11.2 |
11 |
10.9 |
12.7 |
14.1 |
15.1 |
Activated partial thromboplastin time, s (25.1–36.5) |
23.6 |
53.9 |
52.7 |
56.6 |
48.0 |
44.3 |
47.7 |
Fibrinogen, mg/dL |
275 |
NT |
NT |
125 |
135 |
129 |
NT |
Aspartate aminotransferase, IU/L (<35) |
31 |
545 |
549 |
1,259 |
7,547 |
7,644 |
8,330 |
Alanine aminotransferase,e IU/L (<45) |
19 |
141 |
149 |
370 |
2,272 |
2,471 |
2,659 |
Total bilirubin, mg/dL (0.3–1.2) |
NT |
0.81 |
0.93 |
1.49 |
2.57 |
3.92 |
5.34 |
Creatine kinase, IU/L (<171) |
NT |
372 |
NT |
263 |
262 |
246 |
397 |
Lactate dehydrogenase, IU/L (<248) |
285 |
2,278 |
1,879 |
2,495 |
8,655 |
9,712 |
10,980 |
Urine cultures |
NT |
Neg |
NT |
Neg |
NT |
NT |
NT |
Blood cultures | Neg | Neg | NT | Neg | NT | NT | NT |
*CCHFV, Crimean-Congo hemorrhagic fever virus; D, day after symptom onset; Neg, negative; NT, not tested; Pos, positive.
1These first authors contributed equally to this article.
Page created: November 15, 2024
Page updated: December 22, 2024
Page reviewed: December 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.